Z-0896-2022 Class II Terminated

Recalled by DRG International, Inc. — Springfield, NJ

FDA device recall Z-0896-2022 was initiated by DRG International, Inc. on Dec 21, 2021 and is designated Class II. Reason for recall: ODs of the standards too low(< 0.6 ODmax) may cause invalid runs, delayed patient results are possible The recall status is terminated (terminated Feb 12, 2024). Affected quantity: 3 Kits.

Recall details

Product Type
Devices
Report Date
Apr 13, 2022
Initiation Date
Dec 21, 2021
Termination Date
Feb 12, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3 Kits

Product description

C-Peptide ELISA : IVD measurement of C-Peptide in serum, plasma (EDTA-, heparin- or citrate plasma) and urine. Catalog # EIA-1293

Reason for recall

ODs of the standards too low(< 0.6 ODmax) may cause invalid runs, delayed patient results are possible

Distribution pattern

NY

Code information

Lot# / Expiration dates: 20K061 / 2022-06-30 20K071 / 2022-07-31 20K081 / 2022-08-31

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0896-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0896-2022. Report a data issue: hello@regdatalab.com.